Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

RODOLFO GALINDO

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1558532531
CMS profile
1176137
Location
MIAMI, FL

General Payments · PY2019–2025

$229,377.22

  • Reported across 228 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$37,616.36

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $15,474.71 14
Novo Nordisk AS $13,098.66 6
Eli Lilly and Company $3,300.00 1
Amgen Inc. $2,405.26 2
Abbott Laboratories $2,000.00 1
Bayer HealthCare Pharmaceuticals Inc. $714.00 1
DEXCOM, INC. $531.00 1
Lilly USA, LLC $49.83 1
Sequel Med Tech, LLC $23.08 1
SANOFI-AVENTIS U.S. LLC $19.82 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $7,334.87 17
PY2020 $16,044.26 32
PY2021 $14,252.70 9
PY2022 $37,692.91 50
PY2023 $99,891.01 60
PY2024 $16,545.11 31
PY2025 $37,616.36 29

Payment records · PY2025 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $2,000.00 02/11/2025 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 06/30/2026 1240582801 CMS
Amgen Inc. $8.22 12/05/2025 Education Undisputed 06/30/2026 1226904510 CMS
Amgen Inc. $2,397.04 12/23/2025 Consulting Fee Undisputed 06/30/2026 1226905210 CMS
Bayer Healthcare Pharmaceuticals Inc. $714.00 07/15/2025 Consulting Fee Undisputed 06/30/2026 1225544292 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 01/29/2025 Travel and Lodging Undisputed 06/30/2026 1222845999 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6,450.00 01/29/2025 Consulting Fee Undisputed 06/30/2026 1222846001 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 01/29/2025 Food and Beverage Undisputed 06/30/2026 1222846003 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $346.96 09/04/2025 Travel and Lodging Undisputed 06/30/2026 1222846019 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $79.11 10/08/2025 Food and Beverage Undisputed 06/30/2026 1222846005 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $56.55 10/08/2025 Food and Beverage Undisputed 06/30/2026 1222846007 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $103.65 10/08/2025 Food and Beverage Undisputed 06/30/2026 1222846009 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $57.92 10/08/2025 Food and Beverage Undisputed 06/30/2026 1222846011 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $325.84 10/08/2025 Travel and Lodging Undisputed 06/30/2026 1222846015 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $85.68 10/09/2025 Travel and Lodging Undisputed 06/30/2026 1222846013 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $194.00 10/09/2025 Travel and Lodging Undisputed 06/30/2026 1222846017 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 11/24/2025 Travel and Lodging Undisputed 06/30/2026 1222846021 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 11/24/2025 Food and Beverage Undisputed 06/30/2026 1222846023 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7,425.00 11/24/2025 Consulting Fee Undisputed 06/30/2026 1222846025 CMS
Dexcom, Inc. $531.00 10/01/2025 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 06/30/2026 1250518227 CMS
Eli Lilly and Company $3,300.00 08/05/2025 Consulting Fee Undisputed 06/30/2026 1186919974 CMS
Lilly USA, LLC $49.83 03/13/2025 Food and Beverage Undisputed 06/30/2026 1186867999 CMS
Novo Nordisk Inc $2,875.00 10/08/2025 Consulting Fee Undisputed 06/30/2026 1188945683 CMS
Novo Nordisk Inc $8,475.00 10/09/2025 Consulting Fee Undisputed 06/30/2026 1188316913 CMS
Novo Nordisk Inc $495.00 10/09/2025 Travel and Lodging Undisputed 06/30/2026 1188338635 CMS
Novo Nordisk Inc $659.76 10/09/2025 Travel and Lodging Undisputed 06/30/2026 1188691903 CMS
Novo Nordisk Inc $269.00 10/09/2025 Food and Beverage Undisputed 06/30/2026 1188952811 CMS
Novo Nordisk Inc $324.90 10/09/2025 Travel and Lodging Undisputed 06/30/2026 1189102477 CMS
SANOFI-AVENTIS U.S. LLC $19.82 05/16/2025 Food and Beverage Undisputed 06/30/2026 1233590265 CMS
Sequel Med Tech, LLC $23.08 07/05/2025 Food and Beverage Undisputed 06/30/2026 1243735115 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.